A
$ Value
$0
Shares
10,560
Price
$0
Filed
Feb 17
Insider
Name
Murphy Nicole
Title
Head of Pharm Ops and Tech
CIK
0001910644
Roles
Officer
Transaction Details
Transaction Date
2026-02-13
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,560
Footnotes
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.
Filing Info
Murphy Nicole's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | BIIB | A | $0 |
| 2026-02-12 | BIIB | ▲ | $585 ★ |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $205K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $184K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $283K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | M | $0 |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Murphy Nicole
Head of Pharm Ops and Tech
|
$585 | — | 2026-02-12 |
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |